amygdalin has been researched along with Adenocarcinoma Of Kidney in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaheta, RA; Haferkamp, A; Juengel, E; Makarevic, J; Nelson, K; Rutz, J; Thomas, A; Tsaur, I | 1 |
1 other study(ies) available for amygdalin and Adenocarcinoma Of Kidney
| Article | Year |
|---|---|
Amygdalin inhibits the growth of renal cell carcinoma cells in vitro.
Topics: Amygdalin; Apoptosis; Carcinoma, Renal Cell; CDC2 Protein Kinase; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin B; Cyclin-Dependent Kinases; Gene Expression Regulation, Neoplastic; Humans | 2016 |